Q2 2020 Holdings
Filed 2020-08-14 | 60 holdings | $43.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $9.9M | 80,000 | 22.7% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $9.6M | 55,000 | 22.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $8.0M | 150,000 | 18.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $8.0M | 340,000 | 18.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $3.4M | 250,000 | 7.8% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $2.5M | 25,000 | 5.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $1.9M | 10,000 | 4.3% |
| LHC Group Inc(LHCGUSD) | COM | 50187A107 | $21.8K | 125,000 | 0.1% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $13.7K | 120,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $11.8K | 200,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $11.0K | 175,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $9.2K | 75,000 | 0.0% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $9.1K | 90,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $9.0K | 75,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $8.6K | 150,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $8.6K | 110,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $8.1K | 195,000 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $8.0K | 45,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $7.8K | 20,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $7.6K | 45,000 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.5K | 12,000 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $7.3K | 100,000 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $7.1K | 40,000 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $7.0K | 125,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $6.6K | 125,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $6.1K | 15,000 | 0.0% |
| Universal Hlth Svcs Inc(UHS) | CL B | 913903100 | $6.0K | 65,000 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $5.9K | 25,000 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $5.8K | 75,000 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $5.7K | 35,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.7K | 50,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $5.0K | 150,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $4.8K | 55,000 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $4.6K | 50,000 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $4.4K | 80,000 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $4.3K | 50,000 | 0.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $4.2K | 35,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $3.8K | 25,000 | 0.0% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $3.7K | 175,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $3.6K | 135,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $3.6K | 150,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.5K | 270,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.5K | 18,000 | 0.0% |
| Moderna IncPut | PUT | 60770K957 | $3.2K | 50,000 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $3.1K | 130,000 | 0.0% |
| Perkinelmer Inc(RVTY) | COM | 714046109 | $2.9K | 30,000 | 0.0% |
| Change Healthcare Inc(CHNGUSD) | COM | 15912K100 | $2.8K | 250,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $2.8K | 110,000 | 0.0% |
| Intra Cellular Therapies IncCall | CALL | 46116X901 | $2.6K | 100,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.4K | 20,000 | 0.0% |